Managing psoriasis (PsO) and psoriatic arthritis (PsA) presents multiple challenges for healthcare professionals, including staying up to date with emerging therapies, recognizing early signs of PsA, managing comorbidities, and implementing multidisciplinary care strategies. Despite advances in biologic and systemic therapies, unmet needs persist in timely diagnosis, patient education, and comprehensive disease management. Busy healthcare professionals often lack the time for in-depth study of the latest research, creating a critical need for concise, accessible educational opportunities. These unmet needs point to the necessity of practical, time-efficient programs that provide actionable insights into new treatment protocols and improve patient outcomes.

These podcast episodes are designed to provide healthcare professionals with an in-depth exploration of the most recent advances in the management of psoriasis (PsO) and psoriatic arthritis (PsA). The segments will focus on key challenges in clinical practice, including early diagnosis, personalized treatment strategies, and the integration of patient-reported outcomes. It will also address the management of associated comorbidities and the latest therapeutic developments, including biologics and small molecules.

Launch Date: March 27, 2025

Release Date: March 27, 2025

Expiration Date: February 28, 2026

FACULTY

Alice Gottlieb, MD, PhD

Clinical Professor, Icahn School of Medicine at Mount Sinai

Mark Lebwohl, MD

Dean for Clinical Therapeutics

Icahn School of Medicine at Mount Sinai

Professor & Chair Emeritus of Kimberly & Eric J. Waldman Dept. of Dermatology

Mount Sinai Health System

Philip Mease, MD

Director, Rheumatology Research, Providence Swedish Medical

Clinical Professor, University of Washington School of Medicine

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Managing psoriasis (PsO) and psoriatic arthritis (PsA) presents multiple challenges for healthcare professionals, including staying up to date with emerging therapies, recognizing early signs of PsA, managing comorbidities, and implementing multidisciplinary care strategies. Despite advances in biologic and systemic therapies, unmet needs persist in timely diagnosis, patient education, and comprehensive disease management. Busy healthcare professionals often lack the time for in-depth study of the latest research, creating a critical need for concise, accessible educational opportunities. These unmet needs point to the necessity of practical, time-efficient programs that provide actionable insights into new treatment protocols and improve patient outcomes.

These podcast episodes are designed to provide healthcare professionals with an in-depth exploration of the most recent advances in the management of psoriasis (PsO) and psoriatic arthritis (PsA). The segments will focus on key challenges in clinical practice, including early diagnosis, personalized treatment strategies, and the integration of patient-reported outcomes. It will also address the management of associated comorbidities and the latest therapeutic developments, including biologics and small molecules.

Launch Date: March 27, 2025

Release Date: March 27, 2025

Expiration Date: February 28, 2026

FACULTY

Alice Gottlieb, MD, PhD

Clinical Professor, Icahn School of Medicine at Mount Sinai

Mark Lebwohl, MD

Dean for Clinical Therapeutics

Icahn School of Medicine at Mount Sinai

Professor & Chair Emeritus of Kimberly & Eric J. Waldman Dept. of Dermatology

Mount Sinai Health System

Philip Mease, MD

Director, Rheumatology Research, Providence Swedish Medical

Clinical Professor, University of Washington School of Medicine

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Managing psoriasis (PsO) and psoriatic arthritis (PsA) presents multiple challenges for healthcare professionals, including staying up to date with emerging therapies, recognizing early signs of PsA, managing comorbidities, and implementing multidisciplinary care strategies. Despite advances in biologic and systemic therapies, unmet needs persist in timely diagnosis, patient education, and comprehensive disease management. Busy healthcare professionals often lack the time for in-depth study of the latest research, creating a critical need for concise, accessible educational opportunities. These unmet needs point to the necessity of practical, time-efficient programs that provide actionable insights into new treatment protocols and improve patient outcomes.

These podcast episodes are designed to provide healthcare professionals with an in-depth exploration of the most recent advances in the management of psoriasis (PsO) and psoriatic arthritis (PsA). The segments will focus on key challenges in clinical practice, including early diagnosis, personalized treatment strategies, and the integration of patient-reported outcomes. It will also address the management of associated comorbidities and the latest therapeutic developments, including biologics and small molecules.

Launch Date: March 27, 2025

Release Date: March 27, 2025

Expiration Date: February 28, 2026

FACULTY

Alice Gottlieb, MD, PhD

Clinical Professor, Icahn School of Medicine at Mount Sinai

Mark Lebwohl, MD

Dean for Clinical Therapeutics

Icahn School of Medicine at Mount Sinai

Professor & Chair Emeritus of Kimberly & Eric J. Waldman Dept. of Dermatology

Mount Sinai Health System

Philip Mease, MD

Director, Rheumatology Research, Providence Swedish Medical

Clinical Professor, University of Washington School of Medicine

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.